These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2570304)

  • 1. Pamidronate and hypercalcaemia of malignancy.
    Lancet; 1989 Sep; 2(8663):617-8. PubMed ID: 2570304
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of bisphosphonates in hypercalcaemia due to malignancy.
    Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
    Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
    [No Abstract]   [Full Text] [Related]  

  • 3. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
    Illidge TM; Hussey M; Godden CW
    Clin Oncol (R Coll Radiol); 1996; 8(4):257-8. PubMed ID: 8871006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypercalcemia of malignancy with intermittent single infusions of 3-amino-1-hydroxypropylidene-1, 1-biphosphonate (APD).
    Rischin D; Bishop JF
    Aust N Z J Med; 1988 Aug; 18(5):736-7. PubMed ID: 3245828
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia.
    Nesković-Konstantinović Z; Mitrović L; Petrović J; Stamatović L; Ristović Z
    Support Care Cancer; 1995 Nov; 3(6):422-4. PubMed ID: 8564348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
    Gurney H; Kefford R; Stuart-Harris R
    Lancet; 1989 Jul; 2(8657):241-4. PubMed ID: 2569054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
    Buckmaster A; Rodda C; Cowell CT; Ogle G; Dorney S
    J Pediatr Endocrinol Metab; 1997; 10(3):301-4. PubMed ID: 9388823
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
    Williams CJ; Smith RA; Ball RJ; Wilkinson H
    Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
    McIntyre HD; Cameron DP; Urquhart SM; Davies WE
    Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate use in two cases of hypercalcaemia secondary to hyperparathyroidism.
    Weatherall M
    N Z Med J; 1992 Sep; 105(942):389. PubMed ID: 1436854
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of diphosphonates in hypercalcaemia due to malignancy.
    Kanis JA; McCloskey EV; Paterson AH
    Lancet; 1990 Jan; 335(8682):170-1. PubMed ID: 1967461
    [No Abstract]   [Full Text] [Related]  

  • 17. Single high dose aminohydroxypropylidene diphosphonate infusions to treat cancer-associated hypercalcaemia.
    Cantwell B; Harris AL
    Lancet; 1986 Jan; 1(8473):165-6. PubMed ID: 2867388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH; Kristiansen JH
    Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy.
    Wimalawansa SJ
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):591-5. PubMed ID: 7828347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
    Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.